Former Cerebral CEO says investors pushed prescribing of stimulants

Key Facts

November 15, 2022 / 3:11 PM / CBS News The former CEO and founder of online mental health care giant Cerebral sent a letter to the company Friday demanding access to "books and records" that he says could reveal whether the startup violated the law, setting the stage for a potential lawsuit.
Kyle Robertson was ousted from the company in May as scrutiny increased over Cerebral's prescribing of stimulants like Adderall, which is used to treat attention-deficit/hyperactivity disorder and is considered a controlled substance.
In the letter obtained by CBS News, Robertson says he was pressured by the company's investors to "sell more stimulants" and believes his ouster was an effort to "scapegoat" him as these investigations arose.
According to the letter, Cerebral did not initially prescribe controlled substances — which are tightly controlled by the Drug Enforcement Administration due to their addictive nature — and only did so at the urging of investors, not Robertson.